Mandolin delivers precision automation tools for specialty drug processing workflows.
Mandolin has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Mandolin's investors include IQ Capital, SV Angel, Maverick Ventures, SignalFire, Greylock.
Mandolin is headquartered in San Francisco, United States.
Mandolin delivers precision automation tools for specialty drug processing workflows.
Mandolin is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mandolin — Funding & Investors." VCBacked, June 25, 2025, https://www.vcbacked.co/company/mandolin. Accessed October 18, 2026.
VCBacked. (2025). Mandolin — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/mandolin
{{cite web |title=Mandolin — Funding & Investors |url=https://www.vcbacked.co/company/mandolin |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated